| INTRODUCTION
Cancer is a challenging disease to treat and is associated with infection and inflammation. The host immune system plays an important role in tumor growth and progression. It has become evident that tumor-elicited immunosuppression is one of the main reasons for tumor evasion of immune surveillance. 1 Tumor-induced immunosuppressive factors that can suppress normal functions of effector T cells are thought to be one of the key reasons for limitations of cancer immunotherapy. 2 Therefore, abolishing tumor-induced immunosuppressive factors on effector T cells is a promising cancer immunotherapeutic strategy.
It has been reported that myeloid-derived suppressor cells (MDSC), which expand in tumor-bearing individuals, mediate immunosuppression through inhibiting NK and T cell functions. ROS and the enzyme arginase 1 (Arg-1). 10, 11 Therefore, it has been proposed that reducing the number or abrogating the suppressive activity of MDSC might have therapeutic effects for cancers.
Resveratrol (RSV) is a pleiotropic phytochemical found in peanuts and grapes, and has been indicated to provide a wide range of health benefits, such as reducing oxidative, inflammatory and apoptotic signals 12 protecting against neurological decline, 13 improving cardiovascular health, 14 ameliorating diabetes 15 and preventing cancers. 16 The anti-cancer properties of RSV through diverse molecular mechanisms have been investigated in a plethora of cellular and animal models but have still not been well elucidated. 17 RSV has also been suggested to activate some immune cells, including macrophages and effector T cells, enhancing its anti-tumor effects. 18, 19 Whether RSV could regulate MDSC through direct cytotoxicity or by impairing its promoting-tumor effects remains unclear. Therefore, the present work addresses the above questions. Our results showed that the administration of RSV to tumor-bearing mice could reduce G-MDSC accumulation in vivo. In vitro, RSV could contribute to the apoptosis of G-MDSC, impair G-MDSC immunosuppressive capacity and enhance CTL. Furthermore, RSV could boost the maturation of M-MDSC and eventually delay tumor progression. These findings indicate that RSV might be a modular of MDSC suppressive function and that RSV could be beneficial for anti-tumor immunity.
| MATERIALS AND METHODS

| Cell lines, mice and tumor models
The Lewis lung carcinoma (LLC) was purchased from the Type Cul- To establish tumor models, C57BL/6 mice were inoculated sub- 
| Drug preparation
For in vivo analysis, carboxymethylcellulose sodium (Aladdin, Shanghai, China) was used to promote the dissolution of RSV (Aladdin, Shanghai, China); then the drug was sequentially diluted to the appropriate concentration in PBS. For in vitro analysis, RSV was dissolved as a 100-μmol/L stock solution in DMSO. 
| Apoptotic assay
| Transwell migration assay
| Flow cytometry analysis
For surface markers, cells from tissues, sorted G-MDSC and 
| Reactive oxygen species staining
Granulocytic myeloid-derived suppressor cells from RSV-treated or untreated groups were incubated with PMA (30 ng/mL) and oxidation-sensitive dye 2, 7-dichlorofluorescin diacetate (DCFDA, 2.5 nmol/L, Invitrogen, Carlsbad, CA, USA) for 1 hour.
After that, ROS produced by G-MDSC were detected by flow cytometry and the fluorescence intensity was analyzed using FlowJo software. 
| T-cell proliferation assay
| Statistical analysis
All statistical analyses were carried out using GraphPad Prism 5.
Results were presented in this study as the mean ± SEM from at 
| Resveratrol decreased granulocytic-myeloidderived suppressor cell accumulation by triggering its apoptosis and decreased recruitment
Next, to determine how RSV decreased G-MDSC accumulation, first, to confirm whether RSV directly affected the survival of G-MDSC, RSV was used to treat G-MDSC. As Figure 2A shows, RSV significantly induced G-MDSC apoptosis at 100 μmol/L. For the 6-hour treatment, RSV induced early apoptosis; conversely, for the 12-hour treatment, RSV mainly induced late apoptosis. In line with these results, the expressions of Bax and cleaved caspase-3 were markedly increased following RSV treatment, whereas Bcl-2 was significantly decreased ( Figure 2B ). Furthermore, we confirmed that 50 or 100 μmol/L RSV did not have obvious effects on normal cells survival (Supplementary Figure S2) .
Published studies also indicate that high mobility group box 1 (HMGB1) could promote MDSC expansion in different conditions [22] [23] [24] and could also be downregulated by RSV in various diseases.
25-27
Therefore, we speculated that the decrease in G-MDSC accumulation might be associated with HMGB1 downregulation in RSV-treated cancer-bearing mice. To confirm the hypothesis, HMGB1
expression in LLC cells treated with RSV was detected. As Figure 2C shows, HMGB1 expression was obviously downregulated in a concentration-dependent manner; furthermore, LLC cell culture supernatant following RSV treatment significantly inhibited the migration of G-MDSC, and rHMGB1 partially reversed the inhibitory effect of supernatant from RSV-treated cancer cells ( Figure 2D ). Taken together, RSV not only directly induced G-MDSC apoptosis but also indirectly inhibited the migration of G-MDSC, which may be associated with downregulating HMGB1 expression in cancer cells.
| Resveratrol impaired the suppressive capability of granulocytic-myeloid-derived suppressor cell on CD8 + T cells
The key characteristic of MDSC is their ability to suppress T-cellinduced anti-tumor immune responses and the immunosuppressive activity of G-MDSC has been linked to Arg-1 expression and ROS production. 28 Therefore, first, the levels of Arg-1 and ROS were detected. As Figure 3A ,B shows, the protein level of Arg-1 and the production of ROS were strikingly decreased after RSV exposure at 
| DISCUSSION
The tumor microenvironment (TME) consists of cancer cells, blood vessels, immune infiltrates, stromal cells and the extracellular matrix, and the complicated milieu promotes immune evasion, tolerance and tumor progression. 31 Immune evasion is a hallmark of cancer. How- 35 This drug has also been found to modulate the status and functions of tumor-associated macrophages to suppress tumor growth. 36, 37 In addition, RSV has the potentiality to influence the MDSC population and function in inflammatory diseases. 38, 39 In the present work, we first demonstrated that RSV could Although G-MDSC and M-MDSC could both impede T cell responses, the latter was more suppressive. 40 Except for immunosuppressive effects on cancer development, more evidence showed that MDSC could accelerate the development of cancers by inducing autophagy, reprogramming metabolic status and supporting cancer cell stemness. [41] [42] [43] It remains unclear whether RSV also modulated M-MDSC in other cancer-bearing mice models. Therefore, in future, we will consider the influence of RSV on M-MDSC in different cancer-bearing models.
In conclusion, in the present work, we first demonstrated that RSV not only decreased the accumulation of G-MDSC but also abrogated its immunosuppressive ability in LLC-bearing mice; furthermore, RSV promoted the M-MDSC differentiation into 
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